Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice. [electronic resource]
Producer: 20160719Description: 1247-54 p. digitalISSN:- 1754-8411
- Actin Cytoskeleton -- drug effects
- Actins -- metabolism
- Animals
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Deoxyglucose -- pharmacology
- Down-Regulation -- drug effects
- Endothelial Cells -- drug effects
- Glycolysis -- drug effects
- Hypoxia-Inducible Factor 1, alpha Subunit -- metabolism
- Immunohistochemistry
- Mice, Inbred NOD
- Mice, SCID
- Neoplasms -- pathology
- Neuroblastoma -- pathology
- Protein Serine-Threonine Kinases -- metabolism
- Proto-Oncogene Proteins c-myc -- metabolism
- Pseudopodia -- drug effects
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase
- Xenograft Model Antitumor Assays
- bcl-2 Homologous Antagonist-Killer Protein -- metabolism
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.